Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Polycystic Ovary Syndrome 2Neoplasms 2Quality of Life 1Pancreatic Neoplasms 1Jaw Cysts 1Fatigue 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Trastuzumab 625Paclitaxel 576Cyclophosphamide 555Docetaxel 484Capecitabine 401Letrozole 376Fulvestrant 326Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 184Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 138Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Breast Neoplasms × coenzyme Q10 × Clear all
NCT07307911 2026-04-08

Co-Pa-N

Damanhour University

Phase 2 Completed
50 enrolled
Breast

Breast Neoplasms

NCT06570811 2025-12-26

Coenzyme Q10 and Chemotherapeutic Toxicity in Breast Cancer Patients

Damanhour University

Phase 2 Completed
40 enrolled
Breast

Breast Neoplasms

NCT00976131 2022-10-17

Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer

Columbia University

Phase 1 Completed
7 enrolled
Breast

Breast Neoplasms

NCT00096356 2021-09-29

CoQ10

Wake Forest University Health Sciences

Phase 1 Completed
236 enrolled 11 charts
Breast

Breast Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡